News-Papers
Testimonial
Video Gallery
Vitamin C and cancer revisited
Published on Sunday, 18 August 2013
Vitamin C and cancer revisited
About this Comment, Journal Article.
Search
Follow us...
Latest
- Molecular and cellular mechanisms of melatonin in breast cancer
- Modulation of apoptosis by melatonin for improving cancer treatment efficiency: An updated review
- Melatonin as an adjuvant treatment modality with doxorubicin
- Melatonin inhibits aromatase promoter expression by regulating cyclooxygenases expression and activity in breast cancer cells
- Antiestrogens modulate MT1 melatonin receptor expression in breast and ovarian cancer cell lines
- Melatonin reduces lipid peroxidation and nitric oxide during irradiation-induced oxidative injury in the rat liver
- Melatonin in the treatment of cancer: a systematic review of randomized controlled trials and meta-analysis
- Melatonin protects rat liver against irradiation-induced oxidative injury
- Growth Hormone Action as a Target in Cancer: Significance, Mechanisms, and Possible Therapies
- Melatonin alleviates doxorubicin-induced mitochondrial oxidative damage and ferroptosis in cardiomyocytes by regulating YAP expression
- Melatonin inhibits FAK signaling to suppress PD-L1 expression and enhance chemosensitivity in triple-negative breast cancer
- Therapeutic potentials of melatonin in the treatment of lymphoma: A review of current evidence
- Radiomitigation by Melatonin in C57BL/6 Mice: Possible Implications as Adjuvant in Radiotherapy and Chemotherapy
- Targeting growth hormone in cancer: future perspectives
- Tumour-Derived Human Growth Hormone As a Therapeutic Target in Oncology
- Melatonin induces apoptosis and cell cycle arrest in cervical cancer cells via inhibition of NF-κB pathway
- Molecular basis of melatonin protective effects in metastasis: A novel target of melatonin
- GH and IGF1 in cancer therapy resistance
Most Read
- The Di Bella Method (DBM)
- About melatonin - 1996
- All-trans-retinoic acid and cancer
- Biography
- The Di Bella Method Increases by the 30% the survival rate for Pancreas tumors and for this reason should be proposed as first line therapy for this type of cancer
- Chronic Lymphocytic Leukemia: 4 patients, long-lasting remission
- Somatostatin in oncology, the overlooked evidences
- Bibliography
- How effective is chemo therapy?
- Treatment of Low-grade Non-Hodgkin’s Lymphomas at Advanced Stage
- Large B-cells Non-Hodgkin's Lymphoma, Stage IV-AE: a Case Report
- Complete objective response to biological therapy of plurifocal breast carcinoma
- Non-Hodgkin's Lymphoma, Stage III-B-E: a Case Report
- Vademecum
- Frequently Asked Questions
- Declaration recommends eliminate the use of Impact factor for research evaluation
- Non–Small-Cell Lung Cancer Patients with Low Performance Status: study on 28 patients
- Breast cancer: study on 122 cases. The Di Bella Method (DBM) improved survival, objective response and performance status in a retrospective observational clinical study on 122 cases of breast cancer